Core Insights - Shenzhen has identified biomedicine, high-end medical devices, and the health industry as key sectors within the "20+8" industrial cluster, aiming to create a vibrant and complete ecosystem for pharmaceutical and medical device development [1][2] Industry Growth - The output value of Shenzhen's pharmaceutical and medical device industry is projected to increase from 128 billion yuan in 2020 to 157.6 billion yuan by 2024, with an average annual growth rate of 5.3% [1] - The medical device output is expected to rise from 83.1 billion yuan to 102.8 billion yuan, maintaining its position as the highest in the country [1] - By 2024, the total export value of pharmaceuticals and medical devices is anticipated to reach 41.38 billion yuan, with medical device exports alone accounting for 29.85 billion yuan, also the highest in the nation [1] Development Strategy - Shenzhen plans to establish an industrial development framework consisting of "one corridor, two zones, and three bases," focusing on biomedicine innovation and institutional innovation [2] - The "4+4+N" development strategy will target four emerging sectors, including cell and gene therapy, and will promote key projects in research and development as well as international expansion [2] Specialized Bases - The Pingshan District, recognized as a national-level biomedicine industrial base, has developed a support system with 13 specialized parks covering over 2.79 million square meters, achieving an annual compound growth rate of 39.8% in enterprise numbers [2] - The Guangming District has attracted over 900 medical device companies and over 100 biopharmaceutical companies, with the National Biomanufacturing Industry Innovation Center recently commencing operations to enhance collaborative innovation in the Greater Bay Area [3]

12月10日盘后，泡泡玛特(09992)公告称，公司董事会谨此宣布，何愚先生因其他工作安排已辞任非执行董事，自2025年12月10日起生效。 据媒体报道，何愚是黑蚁资本管理合伙人，黑蚁资本在第一期基金募资阶段接触泡泡玛特，并在2017年首次投资泡泡玛特，随后在2018年到2020年又连续 追加了多次投资。2019年5月，何愚获委任为泡泡玛特非执行董事。 泡泡玛特称，"何先生已确认，彼并无对本公司提出索偿，且与董事会并无意见分歧，亦无有关彼辞任之其他事宜须提请本公司股东或香港联合交易所有 限公司垂注。董事会谨此对何先生于其任期内对本公司作出之宝贵工作及贡献表示衷心感谢。" 与此同时，泡泡玛特宣布，吴越先生已获委任为公司非执行董事，自2025年12月10日起生效。 据泡泡玛特披露的简历，吴越，69岁，自2005年11月起担任LVMH大中华区集团总裁，负责监督LVMH多品牌组合在中国市场的业务。在此之前，吴越曾 于2000年2月至2005年10月担任索尼国际音乐娱乐集团亚洲区副总裁，负责其在中国的业务；于1993年8月至2000年2月担任LVMH集团旗下Parfums Christian Dior品牌的总经理及董事 ...

Core Viewpoint - The article discusses the return of internet celebrity Feng Timo to live streaming after nearly a year, highlighting her health recovery and new business venture in the media industry [1][5]. Group 1: Health and Personal Challenges - Feng Timo revealed that her hiatus was due to a recurrence and metastasis of thyroid cancer, for which she has undergone treatment and is now recovering [1]. - She emphasized the importance of maintaining a positive mindset and good health practices as advised by her doctors [1]. Group 2: Career Developments - After parting ways with her previous company, Feng Timo has established her own media company focused on live streaming [1]. - She has a significant online presence, with over 30.39 million followers on Douyin and over 10.01 million on Weibo, indicating her popularity [3]. Group 3: Advocacy and Awareness - Following her cancer diagnosis, Feng Timo has encouraged young women to avoid mental stress and to communicate openly with family and friends [5]. - She has also urged individuals facing online bullying to take legal action to protect themselves [5].

Core Viewpoint - The Shenzhen real estate market is showing signs of recovery as the year-end approaches, with both new and second-hand housing transactions increasing week-on-week, indicating a growing demand from first-time and upgrading buyers, as well as a strong performance in the luxury market [1][6]. Group 1: New and Second-hand Housing Transactions - In the 49th week of the year, new housing transactions reached 807 units, reflecting a week-on-week increase of 4.8%, with residential sales accounting for 608 units, up 7.4% [2]. - The second-hand housing market recorded 1,419 transactions, marking a 6.2% increase week-on-week, achieving a strong start for December [2]. Group 2: Demand Trends - The demand side is also showing improvement, with new commission purchase contracts increasing by 4.8% week-on-week, indicating a sustained rise in home-buying intentions among citizens [3]. - The number of second-hand contracts signed at LeYouJia stores rose by 17.9% week-on-week, with viewing activity increasing by 5.3%, suggesting a robust market interest [3]. Group 3: Buyer Preferences and Market Dynamics - The majority of buyers (83.7%) are targeting properties priced under 10 million yuan, while 16.3% are looking at homes above this price point, indicating that first-time and upgrading buyers dominate the market [4]. - Longgang district has emerged as a benchmark for value, with a 25.4% share of buyer intentions and an average target price of 3.48 million yuan, while central districts like Futian and Nanshan have lower market shares due to higher prices [4][5]. Group 4: Luxury Market Performance - The luxury housing market is performing strongly, with the recent launch of the Qianhai Times Royal Mansion achieving an 80% sales rate on its opening day, indicating high demand for premium properties [6]. - The project, located in a core area of Qianhai, has attracted significant market attention, with 157 client registrations prior to the launch, showcasing the potential for high-end residential developments [6]. Group 5: Overall Market Outlook - The increase in both new and second-hand housing transactions, coupled with the strong sales of premium projects, suggests that a year-end "tailwind" market is forming, with stable demand from first-time and upgrading buyers contributing to a mild recovery in the Shenzhen real estate market [6].

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. has received acceptance for its IPO on the Sci-Tech Innovation Board, focusing on high-end scientific instrument development for various fields including quantum technology and biomedicine since its establishment in December 2016 [1] Group 1: Company Overview - Guoyi Quantum aims to provide high-end scientific instruments to global universities and research institutions, adhering to the philosophy of "Creating Instruments for the Nation" [1] - The actual controllers of the company, He Yu and Rong Xing, hold a combined 34.87% voting rights, with both being PhD graduates from the University of Science and Technology of China [1] Group 2: Financial Performance - The company's revenue for the reporting period (2022 to 2025) is projected to grow from 151 million to 501 million, with a compound annual growth rate of 81.94% [2] - Despite revenue growth, the company has not yet achieved profitability, with net profits projected to improve significantly by 2025 and expected to turn positive in 2026 [2] - Cumulative R&D investment over the last three years amounts to 361 million, representing 34.29% of total revenue [2] Group 3: Cash Flow and Management - The company has consistently reported negative net cash flow from operating activities, although the outflow has been decreasing over time [3] - Key management personnel have seen salary increases during the reporting period, with total compensation rising from 4.19 million to 5.01 million [3] Group 4: Client Base and Accounts Receivable - The company serves a diverse range of domestic and international clients, with the top five clients contributing a decreasing percentage of total revenue, from 26.62% to 13.41% [3] - Accounts receivable have increased significantly, with the balance reaching 1.47 billion by mid-2025, representing 86.08% of revenue for that period [3] Group 5: IPO and Fundraising - The company plans to raise approximately 1.169 billion for high-end scientific instrument projects, quantum technology research, and application center network construction [4]

Core Viewpoint - Mido Duo Group has submitted an IPO application to the Hong Kong Stock Exchange, aiming to leverage its position as a leading and rapidly growing comprehensive service platform for cross-border e-commerce businesses [1] Group 1: Company Overview - Mido Duo Group provides digital marketing and operational support services to cross-border e-commerce enterprises, enabling them to sell Chinese-manufactured goods to overseas consumers [1] - The company is the fifth largest cross-border e-commerce service provider in mainland China based on projected revenue for 2024 [1] Group 2: Financial Performance - Revenue for Mido Duo Group from 2022 to 2024 is projected to be $65.17 million, $70.85 million, and $71.13 million respectively, with profits of $1.64 million, -$16.41 million, and -$0.163 million [1] - The gross profit for the same period is expected to be $5.182 million, $2.931 million, and $3.119 million, with gross margins of 8%, 4.1%, and 4.4% respectively [1] - In the first half of 2025, the company reported revenue of $55.78 million, up from $30.72 million in the same period the previous year, with a loss of $19.85 million [1] Group 3: Revenue Composition - The overseas marketing service is the core business line, generating $55.035 million in revenue in the first half of 2025, accounting for 98.7% of total revenue [2] - The overseas e-commerce operation and digital exhibition services contributed $35.2 thousand and $39.2 thousand respectively, making up 0.6% and 0.7% of total revenue [2] Group 4: Customer and Supplier Concentration - Mido Duo Group has a high customer concentration, with the top five clients accounting for 37.2% of revenue in the first half of 2025, down from 62.2% in 2022 [2] - The company relies heavily on a few suppliers, with the top five suppliers accounting for 96.5% of procurement, including Google and TikTok, which together represent 91.0% [2] - A significant reduction in Google's rebate rate from 8.9% to 3.2% has led to a 3.9 percentage point decline in gross margin, highlighting the impact of platform policy changes on profitability [2] Group 5: Shareholding Structure - Prior to the IPO, the chairman Ruan Weixing holds 41.27% of the issued share capital through RUANQi Holding, making him the controlling shareholder [3] - CEO Deng Hai holds 21.49% through INMI Holding, while Lu Xiaokun holds 5.39% through LUXK Holding [3]

Group 1 - The company announced the public transfer of 100% equity of its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with an initial listing price of 35.93 million yuan, which was later reduced by 20% to 28.74 million yuan due to lack of interest from potential buyers [1] - The company also attempted to transfer 51% equity of its subsidiary, Puluo New Energy Technology (Taixing) Co., Ltd., with an initial price of 30.49 million yuan, which was subsequently reduced to 24.39 million yuan and then to 18.29 million yuan, ultimately reaching a fourth listing price of 12.20 million yuan after three unsuccessful attempts [2] - The company has been facing financial difficulties, reporting net losses of 26.19 million yuan, 156 million yuan, and 297 million yuan from 2022 to 2024, indicating a trend of "cutting losses to survive" [2] Group 2 - For the first three quarters of 2025, the company reported a revenue of 582 million yuan, a year-on-year decrease of 7.2%, while the net loss narrowed from 76.20 million yuan to 60.46 million yuan [3] - In the third quarter, the company achieved a revenue of 215 million yuan, a year-on-year increase of 4.3%, but the net loss widened from 19.96 million yuan to 22.84 million yuan [3] - The company's operating cash flow showed a significant improvement, with a net cash flow of 47.89 million yuan, representing a year-on-year increase of 162.6% [3]

Core Viewpoint - Tianyuan Dike (300047) announced that its chairman, Chen You, has been placed under detention by the Jingdezhen Lepin City Supervisory Committee, with the company currently unaware of the developments or conclusions regarding this matter [1]. Group 1: Company Leadership and Governance - Chen You, aged 61, has been with the company in various roles since 1993 and has served as chairman since April 2007. His total pre-tax compensation from the company in 2024 was 1.0952 million yuan [1][2]. - The company maintains a robust governance structure and internal control mechanisms, asserting that the board of directors is functioning normally and that operational management is stable [3]. Group 2: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 6.3 billion yuan, reflecting a year-on-year increase of 12.44%. The net profit attributable to shareholders was 386.03 million yuan, up 19.75% year-on-year [3][4]. - The company’s basic earnings per share for the reporting period was 0.0058 yuan, representing a 123.08% increase compared to the previous year [4]. Group 3: Market Reaction - Following the announcement regarding Chen You, the company's stock price fell by 14.55%, closing at 12.33 yuan per share, with a total market capitalization of 7.863 billion yuan [4][5].

12月9日，雅居乐（3383.HK）股价大跌创历史新低，截至当天收盘，报0.31港元/股，股价下跌了 18.42%。 消息面上，12月9日，雅居乐正式收到合作伙伴新濠（中山）企业管理有限公司提交的清盘呈请，涉及 未付款项合计1858.71万美元及223.43万港元，款项源自2025年9月25日中国国际经济贸易仲裁委员会的 仲裁裁决 。案件已排期至2026年2月25日上午9点30分聆讯。 对此，雅居乐集团表示，公司将极力反对呈请。然而，鉴于公司清盘条例第182条的影响，董事会谨此 提醒公司股东及潜在投资者，倘公司最终清盘，在未获得高等法院认可令的情况下，于起始日或之后作 出的公司股份转让将属无效。公司目前无意就公司股份转让向高等法院申请认可令。公司将在稍后阶段 结合其境外债务综合解决方案的进度，考虑是否有必要向高等法院申请认可令。 尽管已收到呈请，公司仍将继续积极与境外债权人沟通合作，透过对集团境外债务进行全面重组，目标 是尽快与主要境外债权人组别就初步重组条款达成协议。同时，公司正积极与呈请人沟通，力求与呈请 人协商达成有效解决方案（包括努力促使呈请尽快被撤回或驳回）。 此前，雅居乐2024年年报披露，截至2 ...

值得注意的是，深交所将迎来H股回A首家企业。港股龙头公司光大环境宣布启动"回A"计划，拟在深 交所上市。 今年11月14日，光大环境公告称，拟发行不超过8亿股A股，计划登陆深交所。这是中办、国办印发 《关于深入推进深圳综合改革试点深化改革创新扩大开放的意见》后，首家宣布回A的粤港澳大湾区港 股企业。 后续还有哪些港股公司回A？以深交所为例，按照深交所红筹企业回A条件，已在境外上市的红筹企业 在深市主板二次上市的标准为：市值不低于2000亿元；市值200亿元以上，拥有自主研发、国际领先技 术，科技创新能力较强，在同行业竞争中处于相对优势地位。 截至12月9日，在港交所上市且未在A股上市的粤港澳大湾区企业中，满足市值超过2000亿元的企业有3 家，分别为腾讯控股、港交所、腾讯音乐；而满足市值200亿元以上要求的企业逾20家，典型企业包括 小鹏汽车-W、华润电力、比亚迪电子、思摩尔国际、优必选、金蝶国际、晶泰控股、中国燃气、名创 优品、小马智行-W、高伟电子、华润饮料、文远知行-W等。 （原标题：H股回A迎来年内首家公司 百奥赛图今日登陆科创板，深交所也将迎来H股回A首家企业） H股回A迎来年内首家公司。百奥赛图1 ...